Please login to the form below

Not currently logged in
Email:
Password:

Catabasis hires Rick Modi as its chief business officer

Will help the firm develop its flagship Duchenne muscular dystrophy product

The US biotech firm Catabasis Pharmaceuticals has named Rick Modi as its new chief business officer. 

Modi brings to Catabasis 15 years of experience in corporate, business and product commercialisation strategy.

Jill Milne, co-founder and chief executive of Catabasis, said: “Rick has valuable experience across multiple brands, including orphan drug positioning, commercialisation and marketing. 

“We look forward to leveraging his capabilities as we advance our clinical development pipeline, particularly CAT-1004 for Duchenne muscular dystrophy (DMD), and our lipid programmes, CAT-2003 and CAT-2054.”

Modi added: “Catabasis has a novel approach to drug development that allows for simultaneous modulation of multiple targets in a disease pathway, and I am privileged to join this team as we seek to bring disease-modifying treatments to patients with DMD or severe lipid disorders."

Prior to joining Catabasis, Modi was senior vice president, global marketing at InterMune - an orphan drug company that was acquired by Roche late last year.

He played a large role in the launch of InterMune's flagship product, the lung-scarring drug Esbriet (pirfenidone)

Modi has also held roles of increasing responsibilities in corporate strategy, new product planning and sales and marketing at AstraZeneca's biologics arm MedImmune as well as J&J's subsidiary Centocor.

16th February 2015

From: Research, Healthcare

Share

Tags

COVID-19 Updates and Daily News

Featured jobs

PMHub

Add my company
certain health

Transforming the way health brands and companies communicate, we deliver creative science led, insight-driven solutions that give award winning results...

Latest intelligence

The Patient Will See You Now – The Evolution of the Doctor-Patient Relationship
The doctor-patient relationship is an ever changing one that changes as society changes. Technology then helps to drive this change along with a wide number of other factors....
Mind the Gap – Challenging Immunisation Apathy and Misinformation
world, the biggest challenges remain apathy and misinformation. Since a measles vaccine was introduced in the UK in 1968, Public Health England estimates that 20 million measles cases and 4,500...
Towards Better HCP Engagement – An Email Masterclass
6% of HCPs prefer being contacted by email, compared to 17% who favour the second most popular option: direct interaction with reps....